Biomarkers of Cardiovascular Risk: State of the Art

Biomarkers of Cardiovascular Risk

October 30-31, 2007

Upcoming Events

Outreach Forum:
Alternative Strategies to Managed Care Contracts
July 17, 2008

Phlebotomy Forums:
Strategies for Retaining Your Best People
Wednesday, July 23, 2008

Disease Management Strategies:
Vitamin D Deficiency: Bones and Beyond
August 5, 2008

Process Improvement: Standardized Work
August 11, 2008

Contact Information

Mayo Medical Laboratories
Education Department

E-Mail Address
Phone: 800.533.1710
Fax: 507.284.8016
Global: 507.284.3156

Biomarkers of Cardiovascular Risk:

State of the Art

October 30-31, 2007
Leighton Auditorium
Harold W. Siebens Medical Education Building
Mayo Clinic, Rochester, Minnesota

Description

This conference provides an overview of advances in the use of biomarkers in cardiovascular risk stratification in asymptomatic individuals, in particular the use of proteomic markers. Topics will include the assessment of atherosclerotic burden, testing of arterial function, emerging markers, current approaches to cardiovascular risk stratification, statistical approaches to biomarker validation, novel platforms, regulatory issues, and perspectives from industry.

Learning Objectives

Upon completion of the conference, participants should be able to:

  • Describe how atherosclerosis biology is relevant to developing new biomarkers of cardiovascular risk
  • Develop insight into the use of arterial function testing, computed tomography (CT), and magnetic resonance imaging (MRI) in cardiovascular risk stratification
  • Interpret how markers of inflammation, thrombogenicity, and other etiologic pathways may improve risk prediction
  • Discuss use of multiplex biomarker panels and statistical approaches to interpret results of multiplex testing
  • Evaluate updates on the latest platforms for multimarker testing
  • Explain the transitioning of a new biomarker toward a clinically useful test and discuss perspectives from industry and regulatory bodies

Disclaimer

Attendance at this Mayo conference does not indicate nor guarantee competence or proficiency in the performance of any procedures that may be discussed or taught in this course.

Intended Audience

This conference is designed for cardiovascular specialists, preventive cardiologists, internists, research fellows, scientists, and clinical chemists. It is intended for individuals interested in the use of circulating biomarkers in cardiovascular risk stratification.

Date and Location

The Biomarkers of Cardiovascular Risk: State of the Art conference will be held October 30-31, 2007, at Leighton Auditorium, Harold W. Siebens Medical Education Building in Rochester, Minnesota.

Credit

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this educational activity for a maximum of 11.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Key